Durable responses after donor lymphocyte infusion for patients with residual multiple myeloma following non-myeloablative allogeneic stem cell transplant-Reference-Cited by-同舟云学术

Durable responses after donor lymphocyte infusion for patients with residual multiple myeloma following non-myeloablative allogeneic stem cell transplant

Published:2012-03 Issue:8 Volume:53 Page:1525-1529
ISSN:1042-8194
Container-title:Leukemia & Lymphoma
language:en
Short-container-title:Leukemia & Lymphoma

Author:

Beitinjaneh Amer M.,Saliba Rima,Bashir Qaiser,Shah Nina,Parmar Simrit,Hosing Chitara,Popat Uday,Anderlini Paolo,Dinh Yvonne,Qureshi Sofia,Rondon Gabriela,Champlin Richard E.,Giralt Sergio A.,Qazilbash Muzaffar H.

Publisher

Informa UK Limited

Subject

Cancer Research,Oncology,Hematology

Link

http://www.tandfonline.com/doi/pdf/10.3109/10428194.2012.656635

Reference28 articles.

1. Reduced-intensity conditioning allogeneic SCT as salvage treatment for relapsed multiple myeloma

2. High response rate in refractory and poor-risk multiple myeloma after allotransplantation using a nonmyeloablative conditioning regimen and donor lymphocyte infusions

3. Prospective comparison of autologous stem cell transplantation followed by dose-reduced allograft (IFM99-03 trial) with tandem autologous stem cell transplantation (IFM99-04 trial) in high-risk de novo multiple myeloma

4. A Comparison of Allografting with Autografting for Newly Diagnosed Myeloma

5. A prospective PETHEMA study of tandem autologous transplantation versus autograft followed by reduced-intensity conditioning allogeneic transplantation in newly diagnosed multiple myeloma

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Allogeneic stem cell transplantation in multiple myeloma: is there still a place?;Frontiers in Oncology;2024-06-04

2. The graft versus leukemia effect: donor lymphocyte infusions and cellular therapy;Frontiers in Immunology;2024-03-15

3. Harnessing the Immune System to Fight Multiple Myeloma;Cancers;2021-09-10

4. Allogeneic Stem Cell Transplantation in Patients with High-Risk Multiple Myeloma: Utopia or Continuous Challenge in Aiming for Cure?;Current Treatment Options in Oncology;2021-06-10

5. Bispecific Antibodies: A New Era of Treatment for Multiple Myeloma;Journal of Clinical Medicine;2020-07-09